287 results on '"Gaujoux-Viala, Cécile"'
Search Results
2. Participation of gut microbiota and bacterial translocation in chronic systemic inflammation in recently diagnosed rheumatoid arthritis patients
Catalog
Books, media, physical & digital resources
3. 2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
4. Actualisation 2024 des recommandations de la Société française de rhumatologie pour le diagnostic et la prise en charge des personnes souffrant de polyarthrite rhumatoïde
5. Clinical and imaging outcomes of different phenotypes of axial spondyloarthritis: 5-year analysis of the DESIR cohort
6. Impact de la multimorbidité sur la réponse thérapeutique aux traitements de fond antirhumatismaux dans la polyarthrite rhumatoïde récente : données de la cohorte Espoir
7. Intérêt de l’IRM et de l’échographie dans la détection de l’arthrose interphalangienne précoce
8. MRI and ultrasonography for detection of early interphalangeal osteoarthritis
9. Impact of multimorbidity on disease modifying antirheumatic drug therapy in early rheumatoid arthritis: Data from the ESPOIR cohort
10. Délai d’initiation d’une biothérapie dans la cohorte française ESPOIR
11. Time to initiation of biologic disease-modifying antirheumatic drugs in the French cohort ESPOIR
12. IL-10-producing regulatory B cells are present and functional in primary Sjögren patients
13. Update of French society for rheumatology recommendations for managing rheumatoid arthritis
14. Actualisation des Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde
15. Efficacy and safety of biological DMARDs modulating B cells in primary Sjögren's syndrome: Systematic review and meta-analysis
16. Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System
17. The 2010 ACR/EULAR criteria are not sufficiently accurate in the early identification of autoantibody-negative rheumatoid arthritis: Results from the Leiden-EAC and ESPOIR cohorts
18. Évaluation de l’activité de la polyarthrite rhumatoïde
19. Conventional radiography in juvenile idiopathic arthritis: Joint recommendations from the French societies for rheumatology, radiology and paediatric rheumatology
20. Version patient des recommandations de prise en charge de la polyarthrite rhumatoïde : une collaboration entre la Société française de rhumatologie et des associations de patients atteints de polyarthrite rhumatoïde
21. Correction to: IL-10-producing regulatory B cells are present and functional in primary Sjögren patients
22. Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis
23. Recommandations de la Société française de rhumatologie pour la prise en charge de la polyarthrite rhumatoïde
24. Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain
25. Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta‐Analysis
26. La main rhumatoïde
27. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis
28. Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort
29. Impact of co-morbidities on measuring indirect utility by the Medical Outcomes Study Short Form 6D in lower-limb osteoarthritis
30. Aspects médico-économiques de la polyarthrite rhumatoïde
31. Abatacept therapy and safety management
32. Evaluating disease activity in rheumatoid arthritis: Which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI
33. Langerhans’ cell histiocytosis of the liver in adults
34. Optimizing methotrexate therapy in rheumatoid arthritis: A systematic literature review
35. Osteomyelitis in adults: An underrecognized clinical entity in immunocompetent hosts. A report of six cases
36. Ostéomyélite de l’adulte : une entité clinique méconnue chez l’immunocompétent. À propos de six cas
37. The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort
38. Optimisation de l’usage du méthotrexate dans la polyarthrite rhumatoïde : analyse systématique de la littérature
39. Évaluation de l’activité de la polyarthrite rhumatoïde, quel indice composite faut-il utiliser ?
40. Comparaison des performances de l’échographie mode B et de l’imagerie par résonance magnétique pour la recherche d’érosions osseuses au cours de la polyarthrite rhumatoïde : analyse systématique de la littérature et méta-analyse
41. Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta‐Analysis.
42. Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis: A Critical and Systematic Review
43. When and for how long should glucocorticoids be used in rheumatoid arthritis? International guidelines and recommendations
44. Patient Global Assessment of Disease Activity and Radiographic Progression in Early Arthritis: Three‐Year Results From the ESPOIR Cohort
45. Associations Between Safety of Certolizumab Pegol, Disease Activity, and Patient Characteristics, Including Corticosteroid Use and Body Mass Index
46. Patient global assessment and radiographic progression in early arthritis: 3‐year results from the ESPOIR cohort
47. Most Appropriate Conventional Disease‐Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta‐Analysis
48. Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
49. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
50. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.